ICI Summit Europe 2017

With over 1000 checkpoint trials currently underway, it is more important than ever to benchmark your progress and learn exactly what it will take to realise success in this field.

Focused specifically on immune checkpoint modulators, the ICI Europe Summit is not just another broad immuno-oncology meeting. It focuses specifically on the preclinical, translational and clinical challenges that drug developers face in advancing more checkpoint inhibitors into the market.

This meeting has been researched and developed with over 40 leading organizations in IO, and incorporates the perspectives of Merck MSD, Innate Pharma, Prima Biomed, EMD Serono and many others.

Join the leaders of the immuno-oncology community in Munich to seize on the wealth of opportunities to ensure that you:

• Identify robust, clinically relevant biomarkers
• Enhance the synergy of novel pathway combinations
• Identify the next generation therapeutic platforms enhancing checkpoint success
• Optimise your preclinical modelling strategy

For more information, the full agenda and speaker faculty, please visit: http://bit.ly/2xJ6v3u